Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT

Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT

Background: Both oral contraceptive pills (OCPs) and estradiol valerate (E2) have been used to schedule a gonadotropin-releasing hormone antagonist in vitro fertilization (IVF) cycles. Since the suppression of follicle-stimulating hormone by OCPs can stay 5-7 days after stopping the pills, it seems...

Full description

Bibliographic Details
Main Authors: Ensieh Shahrokh Tehrani Nejad, Fatemeh Bakhtiari Ghaleh, Bita Eslami, Fedyeh Haghollahi, Maryam Bagheri, Masoumeh Masoumi
Format: Article
Language:English
Published: Shahid Sadoughi University of Medical Sciences 2018-08-01
Series:International Journal of Reproductive BioMedicine
Subjects:
IVF
GnRH antagonist
Oral contraceptives
Estradiol.
Online Access:http://journals.ssu.ac.ir/ijrmnew/browse.php?a_code=A-10-1-602&slc_lang=en&sid=1

Similar Items

Similar Items